HCPCS Level II J1458: Injection, galsulfase, 1 mg
HCPCS Level II code J1458 represents the billed drug product galsulfase, 1 mg, for injection, typically used as an enzyme replacement therapy administered by intravenous infusion; service type is drug administration and the typical site of service is an outpatient infusion center or hospital outpatient department.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J1458 policy alerts
Get alerted when payer policies referencing J1458 are released or updated.
Monitor payer policy activity